Breast cancer, with around 2 million new cases in 2019, is the second most common cancer
worldwide and the second leading cause of cancer death among females. The aim of this …

Cancer is a global health challenge. There are drawbacks to conventional chemotherapy
such as poor bioavailability, development of drug resistance and severe side effects. Novel …

The development of natural phospholipids for nanostructured drug delivery systems has
attracted much attention in the past decades. Lecithin that was derived from naturally …

Over thousands of years, natural bioactive compounds derived from plants (bioactive
phytocompounds, BPCs) have been used worldwide to address human health issues …

Biofilm formation by pathogenic microorganisms has been a tremendous challenge for
antimicrobial therapies due to various factors. The biofilm matrix sequesters bacterial cells …

Liposomes are a promising nanocarrier for drug delivery because of their biocompatibility
and the encapsulation capacity of drugs. Liposomes can be functionalized easily by …

Nanobiotechnology is a relatively unexplored area that has, nevertheless, shown relevant
results in the fight against some diseases. Antimicrobial peptides (AMPs) are …

New polymeric systems are constantly developed for novel biomedical applications.
Pluronic F127 (PF127) is a tri-block copolymer with surface-active properties. It comprises a …

It is verified that failure in cancer therapy by conventional chemotherapeutic agents arise
from cancer heterogeneity. That, a small subpopulation of cancer cells known as “cancer …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …